Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study

被引:461
|
作者
Ayoubkhani, Daniel [1 ]
Khunti, Kamlesh [2 ]
Nafilyan, Vahe [1 ]
Maddox, Thomas [1 ]
Humberstone, Ben [1 ]
Diamond, Ian [1 ]
Banerjee, Amitava [3 ,4 ,5 ]
机构
[1] Off Natl Stat, Govt Bldg, Newport, Gwent, Wales
[2] Univ Leicester, Diabet Res Ctr, Leicester, Leics, England
[3] UCL, Inst Hlth Informat, London NW1 2DA, England
[4] Univ Coll London Hosp NHS Trust, London, England
[5] Royal London Hosp, Barts Hlth NHS Trust, London, England
来源
关键词
D O I
10.1136/bmj.n693
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To quantify rates of organ specific dysfunction in individuals with covid-19 after discharge from hospital compared with a matched control group from the general population. DESIGN Retrospective cohort study. SETTING NHS hospitals in England. PARTICIPANTS 47 780 individuals (mean age 65, 55% men) in hospital with covid-19 and discharged alive by 31 August 2020, exactly matched to controls from a pool of about 50 million people in England for personal and clinical characteristics from 10 years of electronic health records. MAIN OUTCOME MEASURES Rates of hospital readmission (or any admission for controls), all cause mortality, and diagnoses of respiratory, cardiovascular, metabolic, kidney, and liver diseases until 30 September 2020. Variations in rate ratios by age, sex, and ethnicity. RESULTS Over a mean follow-up of 140 days, nearly a third of individuals who were discharged from hospital after acute covid-19 were readmitted (14 060 of 47 780) and more than 1 in 10 (5875) died after discharge, with these events occurring at rates four and eight times greater, respectively, than in the matched control group. Rates of respiratory disease (P<0.001), diabetes (P<0.001), and cardiovascular disease (P<0.001) were also significantly raised in patients with covid-19, with 770 (95% confidence interval 758 to 783), 127 (122 to 132), and 126 (121 to 131) diagnoses per 1000 person years, respectively. Rate ratios were greater for individuals aged less than 70 than for those aged 70 or older, and in ethnic minority groups compared with the white population, with the largest differences seen for respiratory disease (10.5 (95% confidence interval 9.7 to 11.4) for age less than 70 years v 4.6 (4.3 to 4.8) for age >= 70, and 11.4 (9.8 to 13.3) for non-white v 5.2 (5.0 to 5.5) for white individuals). CONCLUSIONS Individuals discharged from hospital after covid-19 had increased rates of multiorgan dysfunction compared with the expected risk in the general population. The increase in risk was not confined to the elderly and was not uniform across ethnicities. The diagnosis, treatment, and prevention of post-covid syndrome requires integrated rather than organ or disease specific approaches, and urgent research is needed to establish the risk factors.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Post-COVID syndrome: A single-center questionnaire study on 1007 participants recovered from COVID-19
    Kayaaslan, Bircan
    Eser, Fatma
    Kalem, Ayse K.
    Kaya, Gamze
    Kaplan, Betul
    Kacar, Duygu
    Hasanoglu, Imran
    Coskun, Belgin
    Guner, Rahmet
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (12) : 6566 - 6574
  • [42] Post-COVID Syndrome
    Hallek, Michael
    Adorjan, Kristina
    Behrends, Uta
    Ertl, Georg
    Suttorp, Norbert
    Lehmann, Clara
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2023, 120 (18): : 327 - 327
  • [43] Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients
    Payam Peymani
    Tania Dehesh
    Farnaz Aligolighasemabadi
    Mohammadamin Sadeghdoust
    Katarzyna Kotfis
    Mazaher Ahmadi
    Parvaneh Mehrbod
    Pooya Iranpour
    Sanaz Dastghaib
    Ahmad Nasimian
    Amir Ravandi
    Biniam Kidane
    Naseer Ahmed
    Pawan Sharma
    Shahla Shojaei
    Kamran Bagheri Lankarani
    Andrzej Madej
    Nima Rezaei
    Tayyebeh Madrakian
    Marek J. Los
    Hagar Ibrahim Labouta
    Pooneh Mokarram
    Saeid Ghavami
    Translational Medicine Communications, 6 (1)
  • [44] An Analysis of Length of Hospital Stay of COVID-19 Patients Admitted in a Dedicated COVID-19 Hospital
    Khajuria, Aayush
    Bobdey, Saurabh
    Kumar, Surinder
    Sahu, Rajesh
    Vashisht, Rohit
    Bhaskar, Vijay
    Faujdar, D. S.
    Yadav, Arun Kumar
    Kaushik, S. K.
    Bhatia, S. S.
    JOURNAL OF MARINE MEDICAL SOCIETY, 2021, 23 (02) : 145 - 148
  • [45] Long COVID in Hospitalized COVID-19 Patients: A Retrospective Cohort Study
    Yaksi, Nese
    Teker, Ayse Gulsen
    Imre, Ayfer
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2022, 51 (01) : 88 - 95
  • [46] Post-COVID Mucormycosis: A Retrospective Observational Study
    Shaik, Nurani
    Bollam, Akhila
    Konduri, Gayathri
    Sekhar, Aedula Vinaya
    INDIAN JOURNAL OF RESPIRATORY CARE, 2022, 11 (03) : 230 - 233
  • [47] Hospital at Home units in the post-COVID 19 era
    Coloma, Emmanuel
    Nicolas, David
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2020, 50 (11)
  • [48] Strain Echocardiography in Acute COVID-19 and Post-COVID Syndrome: More than Just a Snapshot
    Kersten, Johannes
    Schellenberg, Jana
    Jerg, Achim
    Kirsten, Johannes
    Persch, Hasema
    Liu, Yuefei
    Steinacker, Juergen M.
    BIOMEDICINES, 2023, 11 (04)
  • [49] Disease Severity of acute COVID-19 Disease and Post-COVID Syndrome based on Cigarette Consumption
    Laubenstein, G.
    Russ, A.
    Franzpoetter, K.
    Reinke, L.
    Maetzler, C.
    Poick, S.
    Heyckendorf, J.
    Miljukov, O.
    Vehreschild, J.
    Appel, K.
    Chaplinskaya-Sopol, I
    Krist, L.
    Fricke, J.
    Keil, T.
    Witzenrath, M.
    Zoller, T.
    Schmidbauer, L.
    Nuernberger, C.
    Horn, A.
    Stoerk, S.
    Reese, J.
    Heuschmann, P.
    Lieb, W.
    Krawczak, M.
    Schreiber, S.
    Watz, H.
    Bahmer, T.
    PNEUMOLOGIE, 2024, 78 : S26 - S27
  • [50] Post-COVID Syndrome: The Research Progress in the Treatment of Pulmonary sequelae after COVID-19 Infection
    Ruggiero, Valentina
    Aquino, Rita P.
    Del Gaudio, Pasquale
    Campiglia, Pietro
    Russo, Paola
    PHARMACEUTICS, 2022, 14 (06)